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Abstract
In this study, we investigated the relationship between sensory abnormalities evaluated by quantitative sensory testing (QST) 
and alexithymia, depression and anxiety in patients with neuropathic pain involving the upper limbs. We enrolled 62 patients 
(34 with carpal tunnel syndrome, 7 with brachial plexopathy, 3 with cervical painful radiculopathy, 5 with ulnar entrapment 
neuropathy at elbow and 13 with post-burn hypertrophic scars) and 48 healthy controls. All underwent nerve conduction 
studies (NCS), evaluation of cold, heat pain and vibration detection threshold (VDT) by QST and evaluation of alexithymia 
by Toronto Alexithymia Scale (TAS-20), depression by Beck Depression Inventory II (BDI-II), anxiety by State-Trait Anxiety 
Inventory (STAI-Y), level of psychological distress by 12-item General Health Questionnaire (GHQ-12) and perceived social 
support by the Multidimensional Scale of Perceived Social Support (MSPSS). The general linear model analysis revealed a 
significant relationship between TAS-20 overall and TAS-20 sub-score for difficulty identifying feelings and VDT z-scores 
in the left index with no interaction by year of education and sensory NCS results. Our results demonstrated the association 
between impairment of vibratory sensation of the left hand, reflecting cutaneous mechanoceptor dysfunction, and alexithymia, 
particularly the difficulty to identify feelings. The importance of delivering to patients with neuropathic pain personalized 
care that takes into account not only the neurophysiological aspects but also the aspects of mental functioning is discussed.
Keywords Alexithymia · Quantitative sensory testing · Neuropathic pain · Carpal tunnel syndrome
Introduction
The International Association for the Study of Pain (IASP) 
defined pain as “an unpleasant sensory and emotional expe-
rience associated with actual or potential tissue damage, or 
described in terms of such damage” (IASP 2020). Mood 
and behavioral changes have been described in patients with 
chronic pain, and modulation of neural circuits involved in 
motivation regulation is critical for translation between 
acute/subacute and chronic pain (Baliki and Apkarian 2015; 
Vachon-Presseau 2016). A biopsychosocial approach to the 
study and management of pain involves the identification of 
the inter-relationships between neurobiological mechanisms, 
concurrent behavioral and psychological manifestations, and 
environmental factors (Meints and Edwards 2018). Depres-
sion, anxiety and emotional distress are frequent in patients 
with chronic pain and are critical to long-term outcomes 
(Turk et al. 2010; Meints and Edwards 2018).
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Alexithymia (from Greek a: loss, lexis: word, thymia: 
mood or emotion) is a personality construct characterized 
at an intrapersonal level by an impairment in identifying 
feelings, inability to find appropriate words to describe them, 
restricted imagination with a lack of fantasy and heightened 
preoccupation with the external details of events (Sifneos 
1973; Lumley et al. 2007; Lane et al. 2015; Di Tella and 
Castelli 2016; Keefer et al. 2019; Di Tella et al. 2020). 
Described initially in patients with classic psychosomatic 
diseases (Sifneos 1973), substance abuse and posttraumatic 
stress (Lumley et al. 2007; Keefer et al. 2019), alexithymia 
has subsequently been characterized as a major risk factor 
for depression and anxiety (Lumley et al. 2007).
The possible role of alexithymia in chronic pain has been 
addressed in previous studies, demonstrating a variable asso-
ciation with pain intensity (Hosoi et al. 2010; Makino et al. 
2013), but a strong association with depression, anxiety, 
maladaptive early schemas (Saariaho et al. 2015; Di Tella 
and Castelli 2016) and catastrophising (Makino et al. 2013). 
The majority of studies evaluated the presence of alexithy-
mia in patients with chronic primary pain, such as fibromy-
algia (Di Tella et al. 2018), complex regional pain syndrome 
(Margalit et al. 2014) and temporomandibular joint disorder 
(Nicholas et al. 2019), as well as in patients with chronic 
secondary musculoskeletal pain (Perrot et al. 2019).
Chronic neuropathic pain is defined as being caused by 
a lesion or disease of the somatosensory system (Finnerup 
et al. 2016; Scholz et al. 2019). Identification of sensory 
signs, both positive (allodynia) and negative (sensory loss), 
in a neuroanatomically plausible distribution is a critical step 
in grading the certainty of a diagnosis of neuropathic pain 
(Finnerup et al. 2016). Quantitative sensory testing (QST) 
has been recognized as a reliable and reproducible tool for 
the assessment of somatosensory abnormalities in patients 
with neuropathic pain (Geber et al. 2011; Backonja et al. 
2013). QST has been extensively investigated as a potential 
biomarker for the diagnosis of neuropathic pain, subgroup-
ing of patients in clinical trials, and outcome predictions 
following treatment (Smith et al. 2017; Treede 2019; Rosen-
berger et al. 2020). Furthermore, the definition of the associ-
ation between abnormalities of different sensory modalities, 
i.e. the sensory phenotype, may point to a possible underly-
ing pathophysiology of pain (Treede 2019).
Analyses of the correlation between sensory impairment 
and psychological abnormalities have rarely been carried 
out in patient with neuropathic pain. Baron et al. (2017) for 
instance found depressive symptoms more frequently associ-
ated with a sensory phenotype defined by prominent sensory 
loss. However, to our knowledge, no previous studies inves-
tigated the relationship between neuropathic pain, alexithy-
mia and sensory phenotype. To this end, in this study, we 
evaluated the relationship between sensory phenotype and 




The study was approved by the ethic committee of the hos-
pital Citta’ della Salute e della Scienza di Torino. Patients 
and controls gave their informed consent to participate the 
study. Sixty-two patients with neuropathic pain involving at 
least one hand and 48 healthy controls were enrolled. We 
included patients with the following diseases known to cause 
chronic (lasting more than 3 months) peripheral neuropathic 
pain (Finnerup et al. 2016; Scholz et al. 2019; Schug et al 
2019): carpal tunnel syndrome (CTS), brachial plexopathy 
(BP), painful cervical radiculopathy (PR), ulnar neuropathy 
at elbow (UNE), post-burn hypertrophic scars (PBHS). The 
diagnosis of CTS was based on the clinical and neurophysi-
ological criteria set forth by the American Academy of Neu-
rology (1993) and the American Association of Electrodiag-
nostic Medicine (Jablecki et al. 2002). BP was diagnosed on 
the basis of electrodiagnostic (Ferrante 2004) and/or MRI 
findings of brachial plexus disease. Root avulsion (RA) was 
diagnosed by MRI evaluation or direct surgical exploration 
(Wade et al. 2018). PR was diagnosed according to Scholz 
et al. (2019), UNE was diagnosed according to Mondelli 
et al. (2005) and PBHS were defined as previously described 
(Isoardo et al. 2012). Exclusion criteria were: age lower than 
14 years and higher than 80 years; inability to complete the 
QST examination with sufficient accuracy; history of alcohol 
or drug abuse; family or past history, clinical or laboratory 
evidence of cervical central nervous system diseases or poly-
neuropathy involving lower limbs.
All patients (34 with CTS, 7 with BP, 3 with cervical PR, 
5 with UNE and 13 with PBHS) underwent a full clinical 
evaluation, including a Medical Research Council (MRC) 
scale score (Kendall et al., 2005) of their abductor pollicis 
brevis (APB) and abductor digiti minimi (ADM) and pin-
prick, touch and position sense assessments of both upper 
limbs. In addition to evaluating pinprick and touch sense, 
the pain sites were also assessed for signs of allodynia in 
response to brushing, as part of the DN4 questionnaire (Bou-
hassira et al. 2005). Self-reported mean pain intensity in the 
week before examination was graded on an 11-point numeri-
cal rating scale (NRS), with scores ranging from 0 (no pain) 
to 10 (worst possible pain) (Jensen and McFarland 1993).
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Nerve conduction studies (NCS)
Participants underwent bilateral motor NCS of the median 
and ulnar nerves and antidromic sensory NCS of the median, 
radial and ulnar nerves, according to standard techniques 
(Isoardo et al. 2012). Sensory NCS of median nerve were 
recorded from the index finger and of the ulnar from the little 
finger. In patients with BP/RA, PR and UNE, sensory NCS 
of the antebrachial lateral (Goslin and Krivikas 1999) and 
medial cutaneous nerves (Seror 2002) were also performed. 
Comparison of both the antidromic median and ulnar sen-
sory latency to the fourth digit was performed bilaterally in 
patients with PBHS and in participants with clinical suspi-
cion of CTS who had normal motor and sensory conduction 
in the median nerve (Preston 1999; Jablecki et al. 2002). A 
median sensory latency at least 0.5 ms higher than the ulnar 
latency at the fourth digit was considered suggestive of CTS 
(Preston 1999). A needle examination was performed in all 
patients with BP/RA and CTS. NCS and needle examina-
tions were performed with commercially available electrodi-
agnostic equipment (Viking Quest, Carefusion, Wisconsin).
Quantitative sensory testing (QST)
QST was performed to evaluate the thresholds for percep-
tion of cold (CDT), heat-induced pain (HPT), and vibration 
(VDT). CDT, HPT and VDT were evaluated at the palmar 
surface of the index and little finger; CDT and HPT were 
also evaluated at the dorsum of the hand. VDT, CDT and 
HPT were evaluated with a commercially available thermal 
and vibratory stimulation device (Medoc TSA II, Durham, 
North Carolina). HPT was evaluated by the method of lim-
its (Isoardo et al. 2012). Stimulation began at 32 °C and 
increased by a rate of 1 °C per second, until the participant 
perceived a change from a heat sensation to pain, or until the 
temperature of the probe reached 50 °C. Five trials at each 
site were averaged to evaluate the HPT. CDT was evalu-
ated using a staircase method with null stimulations (Isoardo 
et al. 2012). Briefly, three ranges of cooling steps are pre-
sented, beginning with a gross 3 °C decrease in temperature. 
Stimulation began at 32 °C. In this reaction-time-independ-
ent evaluation, the participant was asked to define whether 
or not if s/he had perceived the cooling step. VDT was evalu-
ated by the method of levels with null stimulations. Stimula-
tion began at 0 µm. The participant was asked whether or not 
if s/he had perceived the vibration step. Thresholds for CDT 
and VDT were assessed using a computerized algorithm. 
QST was considered insufficiently accurate if participants 
failed to identify at least two of five null stimuli during CDT 
and/or VDT evaluations.
Hypoesthesia for cold and vibration was defined if 
z-scores for CDT were lower than -2.58, for VDT higher 
than 2.58. For Heat pain hypoesthesia was defined if no pain 
was perceived at 50 °C in all trials for each site. Allodynia 
for heat pain was defined if z-scores were lower than -1.64. 
Sensory profile was defined pooling data from QST and 
clinical evaluation of DN4 questionnaire at painful sites. 
According to Maier et al (2010), loss of thermal or pain 
(either heat or pinprick) sense was labeled as L1, loss of 
vibration or touch sense as L2 and combined loss of thermal/
pain and vibration/touch as L3, and no loss of thermal/pain 
and vibration/touch as L0. Allodynia to heat was labeled as 
G1 and allodynia for mechanical stimulation as G2.
Psychological, health quality and social support 
evaluation
Alexithymia was assessed by means of the validated self-
report questionnaire 20-item Toronto Alexithymia Scale 
(TAS-20) (Bagby et al. 1994a, b). The TAS-20 consists of 
three subscales that investigate the following factors: (F1) 
difficulty in identifying feelings; (F2) difficulty in describ-
ing and communicating feelings; (F3) externally oriented 
thinking. The total score on the questionnaire allows for the 
categorization of subjects according to their alexithymic 
dimension: non-alexithymic (score = 20–51), borderline 
alexithymic (score = 52–60), or alexithymic (score ≥ 61).
The presence of depressive symptoms was assessed using 
the Beck Depression Inventory-II (BDI-II). The BDI-II is a 
21-item validated self-report instrument assessing depres-
sive symptoms over the previous 2 weeks (Beck et al. 1996). 
The total score was obtained considering all items, and 
rated from 0 to 3. A total score of 0–13 indicates minimal 
depression, 14–19 mild depression, 20–28 moderate depres-
sion, and, finally, scores over 29 are indicative of severe 
depression.
The Y form of the State-Trait Anxiety Inventory (STAI-Y) 
was used to assess the presence of anxiety symptoms (Spiel-
berger et al. 1983). This self-report questionnaire is divided 
into two sections, each consisting of 20 items that are scored 
using a 4-point Likert-type scale: the STAI-Y1 assesses cur-
rent feelings of apprehension and tension (state anxiety), 
while the STAI-Y2 evaluates persistent anxiety traits (trait 
anxiety). Each section has a total score ranging from 20 to 
80, with higher scores indicating greater anxiety.
The 12-item General Health Questionnaire (GHQ-12) is 
a self-report questionnaire assessing levels of psychological 
distress (Goldberg and Williams 1988). Items are scored 
on a 1–4 Likert scale, which are subsequently converted 
into binary scores (i.e., scores 0 or 1 = 0, and scores 2 or 
3 = 1, giving a maximum score of 12). Higher scores indi-
cate greater levels of psychological distress with a cut-off 
set to ≥ 4.
The Multidimensional Scale of Perceived Social Support 
(MSPSS) is a validated self-report measure of subjectively 
assessed social support (Zimet et  al. 1988). It provides 
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assessment of three sources of social support: family, 
friends, and significant other. The MSPSS consists of 12 
items, each scored on a 7-point Likert scale. The maximum 
score is 84; higher scores indicate greater perceived support.
Statistical analysis
Results are expressed as mean ± standard deviation (SD). 
The normality of the quantitative parameters distribution 
was analyzed using the Kolmogorov–Smirnov test, and the 
QST parameters that were non-normally distributed were 
log-transformed to be analyzed using parametrical meth-
ods of inferential analysis (Rolke et al. 2006; Isoardo et al. 
2012). Patients’ CDT, HPT and VDT z-scores at each site 
were calculated as follows: 
Analyzing data from patients with bilateral pain may 
overstate statistical significance if the comparison is only 
made for hands (Padua et al. 2005). Since pain frequently 
affects both hands in our series, to avoid this bias, we 
decided to perform the statistical analysis both for the hand 
and for the patients (Padua et al. 2005). The differences 
among the groups of hands/patients (with painful hands, 
with non-painful hands and healthy) were analyzed using 
a Mann–Whitney or Wilcoxon test. Correlations were ana-
lyzed by estimating the parametric r-Pearson correlation 
coefficient. General linear models (GLM) were used to test 
correlations both dividing for group or for class. Categorical 
data were compared using a Chi-square test or Fisher’s exact 
test when appropriate. Statistical analysis was carried out 
using Statistical Package for the Social Sciences software 
version 9.0 (SPSS Inc., Chicago, IL, USA). In all analyses, 
p-values < 0.05 were considered as statistically significant. 
The available sample size of 62 patients allows the study to 
highlight a difference of at least 10% between pathological 
compared to normal of TAS-20 score, reaching a Power of 
80% with a two-tailed alfa error of 0.05. The hypothesized 
10% difference between patients with pain and healthy con-




Thirty-four patients had CTS (21 bilateral, 7 right, 6 left), 
7 BP (3 with concurrent RA; 2 right, 5 left), 3 PR C5-C6 
(1 bilateral, 1 right, 1 left), 5 UNE (2 right, 3 left) and 13 
PBHS. No difference between patients and healthy controls 
(log ∕ ln patient value −mean log ∕ln healthy control values)∕SD log ∕ln healthy control values
was noted either for age (52.7 ± 13.6 vs 48 ± 15.5 years) or 
sex (38 women, 24 men vs 30 women, 18 men). The data 
of patients with BP, PR and UNE were pooled and consid-
ered as other neuropathic pain of the upper limb (ONP). 
Years of education were significantly lower in patients than 
healthy controls (11.3 ± 3.5 vs 14.3 ± 4.7 years, p = 0.01), 
due to a significantly higher number of patients with pri-
mary (5 vs 1 healthy control) and secondary school licenses 
(18 vs 7 healthy controls) and a lower number of gradu-
ates (9 vs 19 healthy controls). In patients,  APB and ADM 
MRC scores were lower than in healthy controls both on 
the right and left side (respectively,  APB right = 4.2 ± 1.3, 
left = 3.5 ± 1.9; ADM right = 4.3 ± 1.2 and left = 4.1 ± 1.6 
vs 5 ± 0 in APB  and ADM, p < 0.0001). Neuropathic 
pain involved hands bilaterally in 30 patients, the right 
hand in 16 and the left hand in 16. All patients and con-
trols were right handed. The mean NRS was 6.2 ± 2.4 and 
DN4 was 5.4 ± 2.2, and did not differ among CTS, PBHS 
and ONP (CTS NRS = 5.7 ± 2.7, DN4 = 5.1 ± 2.4; PBHS 
NRS = 6.3 ± 1.4, DN4 = 6 ± 2.8; ONP NRS = 7.5 ± 1.7, 
DN4 = 6.1 ± 1.7; Kruskal–Wallis NRS p: 0.07, DN4, p: 
0.244). Itching, burning pain and mechanical allodynia were 
significantly more frequent in PBHS (respectively, in 11, 
10 and 8 of 13 patients, respectively, p: 0.002, p: 0.01, p: 
0.007), tactile and pinprick hypoestesia were significantly 
more frequent in ONP (both in 12 of 15 patients, respec-
tively, p: 0.003 and p: 0.002) and tingling was significantly 
more frequent in CTS (in 30 of 34 patients, p: 0.03).
Nerve conduction studies
Results of sensory NCS are summarized in the Table 1. 
The amplitude of bilateral median and ulnar sensory 
action potentials (SAPs) and median sensory con-
duction velocity (SCV) were significantly lower in 
patients than healthy controls. Painful and non-pain-
ful hands had lower median SCVs and median and 
ulnar SAP amplitudes than healthy controls’ hands 
(median SCV painful hands = 47.5 ± 9.7  m/s, non-
painful hands = 48.4 ± 6.7  m/s, healthy controls’ 
hands = 60.7 ± 7.7  m/s; median SAP amplitude pain-
ful hands = 25.2 ± 17, non-painful hands = 30 ± 25.3, 
healthy controls hands = 53.1 ± 21.5  µV; ulnar 
SAP amplitude painful hands = 30.6 ± 17.2, non-
painful  hands  = 28.4  ± 20.2 ,  heal thy controls’ 
hands = 51.1 ± 22.1 µV, all comparison p < 0.001). No 
difference was noted between painful and non-painful 
hand for median (p = 0.63) and ulnar SCV (p = 0.91), 
median (p = 0.62) and ulnar SAP amplitude (p = 0.24). 
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The median motor conduction velocity was significantly 
lower in patients than in healthy controls (respectively, 
right = 52.7 ± 4.7 vs 57.9 ± 6.3; left = 52.9 ± 5.2 vs 
59.6 ± 5 m/s p < 0.01) and median motor latency was 
higher in patients than in healthy controls (respectively, 
right = 4.2 ± 1.1 vs 3.2 ± 0.3; left = 4 ± 1 vs 3.1 ± 0.4 ms 
p < 0.0001) (see Table 2). 
QST evaluation and sensory phenotype
QST results are summarized in Table 3. The log-transformed 
CDT values were significantly lower in the left dorsum, left 
little finger and bilateral index in patients than in controls, 
and ln-transformed VDT scores were higher in the bilat-
eral index and little finger of patients than healthy con-
trols. No significant differences across sides were noted for 
Table 1  Summary of sensory nerve conduction studies results
CTS  carpal tunnel syndrome, m meters, PBHS post-burn hypertrophic scars, s seconds, SAP sensory action potential, SCV sensory conduction 
velocity, µV microVolts
a p < 0.0001 versus healthy controls
b p < 0.001 versus healthy controls
c p < 0.01 versus healthy controls
d p < 0.05 versus healthy controls
Median nerve Ulnar nerve
SCV (m/s) SAP amplitude (µV) SCV (m/s) SAP amplitude (µV)
Right Left Right Left Right Left Right Left
All patients 47.8 ± 8.8a 47.8 ± 9.3a 24.7 ± 16.6a 28.6 ± 20.4a 56.7 ± 7.2 56.9 ± 7.7 28.9 ± 16.8a 32.1 ± 18.6b
CTS 44 ± 7.2a 44.9 ± 8.9 a 21.6 ± 13.9a 25.5 ± 16.2a 59.4 ± 6.3 59.4 ± 8.1 32.4 ± 16.9b 35.8 ± 16.7c
PBHS 52.4 ± 6.4b 49.3 ± 6.5d 23.1 ± 13.8b 25.4 ± 11.4b 49.6 ± 5.9b 50.9 ± 2.1b 17.2 ± 11.1a 21.9 ± 13.7b
Other neuropathic 
pain
56.9 ± 8.1 57.1 ± 7.6 39.6 ± 23.2 39.7 ± 34.6 53.3 ± 5.2d 53.2 ± 3.9 28.7 ± 16.9d 28.9 ± 24.3d
Healthy controls 59.7 ± 7.8 62.2 ± 7.6 49.7 ± 21.2 57.6 ± 21.9 58.5 ± 6.8 58.3 ± 6.8 52.4 ± 22.3 52 ± 22.8
Table 2  Summary of motor 
nerve conduction studies results
CMAP compound muscle action potential, CTS  Carpal Tunnel Syndrome, m = meters, MCV motor conduc-
tion velocity, ms milliseconds, mV milliVolts, ONP other neuropathic pain, PBHS post-burn hypertrophic 
scars, s seconds;
a p < 0.0001 versus healthy controls
b p < 0.001 versus healthy controls
c p < 0.05 versus healthy control
MCV (m/s) CMAP amplitude (mV) Latency (ms)
Right Left Right Left Right Left
Median
 All patients 52.7 ± 4.7b 52.9 ± 5.2b 9.2 ± 4.1 8.8 ± 4.9 4.2 ± 1.1 4 ± 1a
 CTS 52.5 ± 3.9a 53.1 ± 4.5 a 8.9 ± 3.8 8.6 ± 4.1 4.5 ± 1.1a 4.4 ± 1.1a
 PBHS 53.9 ± 8 54.2 ± 6.5c 6.8 ± 3.4 7.9 ± 2.9 3.9 ± 1.9 3.7 ± 0.6b
 ONP 52.4 ± 1.9a 50.9 ± 6.1a 10.3 ± 4.4 10.7 ± 7.6b 3.3 ± 0.4 3.4 ± 0.3
 Healthy controls 57.9 ± 6.3 59.6 ± 5 9.6 ± 4 10.4 ± 5.9 3.2 ± 0.3 3.1 ± 0.4
Ulnar
 All patients 58.6 ± 6.9 59.2 ± 7 8.1 ± 3.1 7 ± 3.4 2.6 ± 0.5 2.7 ± 0.6
 CTS 61 ± 5.1 60.2 ± 5.2 10.1 ± 3.9 8.5 ± 2.8 2.4 ± 0.3 2.5 ± 0.5
 PBHS 59.1 ± 8 61.1 ± 8 6.4 ± 1.6 7.8 ± 3 2.8 ± 0.5 2.9 ± 0.4
 ONP 54.1 ± 6.2 54.1 ± 6.3 6.9 ± 2.3 5.6 ± 4.3 2.6 ± 0.2 2.9 ± 0.8
 Healthy controls 59 ± 6.5 58 ± 6.2 9.9 ± 4.1 7.4 ± 3.8 2.7 ± 0.3 3 ± 0.5
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log-transformed CDT and HPT and ln-transformed VDT 
scores in either patients or controls. When comparisons 
were carried out between hands, painful hands had a lower 
index and little finger log-transformed CDT than non-painful 
hands and healthy controls’ hands (and lower dorsum log-
transformed CDT values than healthy controls’ hands). The 
ln-transformed VDT values were higher in painful hands’ lit-
tle digits than non-painful hands and healthy controls’ hands, 
and in painful hands’ index fingers than in healthy controls’ 
hands. HPT was higher in non-painful hands than in pain-
ful and healthy controls’ hands. Frequency of different pat-
terns of loss and gain of sensory function at painful sites is 
different among CTS, PBHS and ONP: L1 is significantly 
more frequent in PBHS than CTS (8 of 13 patients vs 6 of 
34, p = 0.01) and ONP (0 of 12, p = 0.001) while L3 is more 
frequent in ONP than PBHS (8 of 12 vs 2 of 13, p = 0.01); 
G2 is significantly more frequent in PBHS than CTS (7 of 
13 vs 3 of 34 patients, p = 0.002).
Psychological, health quality and social support 
evaluation
All psychological, health quality and social support evalu-
ations did not differ significantly between CTS, PBHS and 
ONP. When patients were considered together, they had sig-
nificantly higher STAI-Y1, BDI-II, TAS-20 overall, TAS-20 
Table 3  Summary of quantitative sensory testing results and z-scores
CDT Cold Pain Threshold, CTS carpal tunnel syndrome, HPT heat pain threshold, L left, PBHS  post-burn hypertrophic scars, R right, VDT 
vibration detection threshold, µm = micrometrs
z-scores are reported in brackets
a log transformed or ln transformed value p < 0.001 versus healthy controls
b log transformed or ln transformed value p < 0.01 versus healthy controls
c log transformed or ln transformed value p < 0.05 versus healthy controls
Sensory modality Site Side CTS PBHS Other neuropathic pain Healthy controls




31.3 8 ± 0.74c
[− 1.51 ± 3.14]
31.6 ± 0.2




20.8 ± 14.8 b
[− 275.1 ± 423.8]
31.6 ± 0.2
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F1, TAS-20 F3, and GHQ-12 values than healthy controls 
(see Table 4).
Correlation analysis between psychological features
TAS-20 overall correlated with STAI-Y1 (r = 0.49, 
p < 0.0001), STAI-Y2 (r = 0.53, p < 0.0001), BDI-II 
(r = 0.35, p = 0.001), TAS-20 F1 (r = 0.82, p < 0.0001), 
TAS-20 F2 (r = 0.72, p < 0.0001) and TAS-20 F3 (r = 0.48, 
p < 0.0001). TAS-20 F1 correlated with STAI-Y1 (r = 0.55, 
p < 0.0001), STAI-Y2 (r = 0.61, p < 0.0001), BDI-II (r = 0.52, 
p < 0.0001), and GH-12 (r = 0.30, p = 0.01). The GHQ-12 
score correlated with STAI-Y1 (r = 0.48, p < 0.0001), STAI-
Y2 (r = 0.54, p < 0.0001), BDI-II (r = 0.56, p < 0.0001). The 
BDI-II score was significantly correlated with STAI-Y1 
(r = 0.65, p < 0.0001), STAI-Y2 (r = 0.75, p < 0.0001).
Correlation analysis between psychological 
features, QST and neurophysiological findings
In patients, left hand VDT z-scores were significantly cor-
related with TAS-20 overall (index r = 0.38, p = 0.004, lit-
tle finger, r = 0.4, p = 0.003), TAS-20 F1 (index r = 0.42, 
p = 0.001, little finger, r = 0.35, p = 0.01). Left hand CDT 
z-scores were correlated with NRS (index r = −  0.32, 
p = 0.02; little finger r = − 0.38, p = 0.01). Left hand HPT 
z-scores were correlated with STAI-Y1 (dorsum, r = 0.34, 
p = 0.01), and STAI-Y2 (dorsum r = 0.27, p = 0.03). Right 
hand HPT z-scores were correlated with STAI-Y1 (dorsum, 
r = 0.37, p = 0.006). Alexithymic patients had higher VDT 
z-scores in the left index (mean: 2.98 ± 2.22 vs 1.97 ± 1.56 
and 0.31 ± 1.41, p = 0.001) and left little digit (mean: 
2.85 ± 1.92 vs 0.95 ± 2.08 and 0.70 ± 1.02, p = 0.009) than 
borderline alexithymic and non-alexithymic patients. No sig-
nificant difference in TAS-20 overall, TAS-20 F1, TAS-20 
F2 or TAS-20 F3 was evident between patients with pain 
only affecting the right hand and those with pain only affect-
ing left hand (respectively, overall 47.8 ± 8.9 vs 52.8 ± 9.1; 
F1: 17.5 ± 4.8 vs 17.9 ± 5.7; F2: 12.3 ± 4.1 vs 14.1 ± 4.1; 
F3: 18.1 ± 5.0 vs 20.9 ± 2.5). There was a significant inverse 
correlation between TAS-20 overall, TAS-20 F1 scores and 
both the left median (respectively, r =  − 0.38, p = 0.003; 
r = − 0.28, p = 0.03) and left ulnar SAP amplitudes (respec-
tively, r = − 0.52, p < 0.001; r = − 0.38, p = 0.03).
When alexithymia was compared according to sen-
sory phenotype, there was an overall difference of TAS-
20 F1 among L0, L1, L2 and L3 without any interaction 
by the diagnostic group (L0 = 13.2 ± 3.5; L1 = 17.7 ± 8; 
L2 = 18.7 ± 4; L3 = 18.7 ± 6.3, F = 1.47, p = 0.04). Post 
hoc analysis showed a significant difference of TAS-20 F1 
between L0 and L2/3 (p = 0.008).
General linear model analysis
The GLM analysis revealed a significant relationship among 
left index VDT z-scores and TAS-20 overall TAS-20 F1 
and left median SAP amplitude (respectively, β = 33.79, 
F = 10.12, p = 0.002; β = 28.08, F = 11.94, p = 0.001; 
β = 23.78, F = 10.11, p = 0.002). Years of education did not 
Table 4  Summary of psychological, health quality and social support evaluation
BDI-II beck depression inventory-II, CTS carpal tunnel syndrome, GHQ-12 12-item general health questionnairre, MSPSS multidimensional 
scale of perceived social support, PBHS post-burn hypertrophic scars, STAI-Y form Y of the state-trait anxiety inventory, TAS-20 toronto alex-
ithymia scale
a p < 0.001 versus healthy controls
b p < 0.01 versus healthy controls
c p < 0.05 versus healthy controls
Combined patients CTS PBHS Other neuropathic pain Healthy controls
TAS-20 overall 49.4 ± 10a 48.8 ± 8.4c 51.5 ± 13.9c 49.2 ± 10.3 44.4 ± 8.7
TAS-20 F1 17.2 ± 6.2c 16.6 ± 5.5 16.6 ± 7.7 18.9 ± 6.4b 14.3 ± 5
TAS-20 F2 12.8 ± 4 12.4 ± 3.6 13.7 ± 4.5 13.1 ± 4.4 13.3 ± 3.8
TAS-20 F3 19.2 ± 3.9a 19.2 ± 2.8b 21.1 ± 5.1b 17.4 ± 4.5 16.3 ± 3.8
STAI-Y1 40.2 ± 12.6c 37.7 ± 11.5 43.1 ± 18.1 43.6 ± 8.9a 34.7 ± 6.8
STAI-Y2 41.3 ± 10.5 39.6 ± 9.4 43.1 ± 15.2 43.9 ± 8c 38.7 ± 8.2
BDI-II 11.3 ± 8.8a 9.2 ± 7.3c 15.2 ± 11.9c 12.7 ± 8.5 b 5.6 ± 4.6
GHQ-12 3.2 ± 4.6c 1.9 ± 2.3 5.7 ± 7.6 4.1 ± 4.9c 1.3 ± 2.0
MSPSS 66.2 ± 18.4 69.2 ± 12 67.6 ± 21.7 57.8 ± 26.1 70.3 ± 11
 Family 22.4 ± 5.8 22.9 ± 4.5 22.8 ± 7.1 20.7 ± 7.1 22.6 ± 5.8
 Friends 20.1 ± 6.9 20.9 ± 6.1 21 ± 6.1 17.5 ± 9.1 22.8 ± 3.5
 Significant other 23.5 ± 5.7 24.7 ± 3.4 23.6 ± 6.4 20.3 ± 8.5 24.1 ± 4.5
68 G. Isoardo et al.
1 3
influence the relationship between VDT z-scores and either 
TAS-20.
Discussion
Our results demonstrated the association between impair-
ment of vibratory sensation of the left hand, reflecting cuta-
neous mechanoceptor dysfunction, and alexithymia, particu-
larly the capacity to identify feelings as expressed by the 
TAS-20 F1 sub-score. This relationship is not dependent 
on educational level. Importantly, the relationship of alex-
ithymia to sensory impairment is limited only to the left 
hand. Log-transformed CDT and HPT, and particularly ln-
transformed VDT, did not differ significantly between right 
and left upper limbs, either in healthy controls or in patients. 
This observation points out that the relationship between 
alexithymia and sensory impairment of the left hand is not 
biased by an unequal distribution of sensory abnormalities 
between the upper limbs in our series. Furthermore, TAS-20 
F1 is significantly higher when sensory phenotype is domi-
nated by impairment of vibration or tactile perception then 
when no sensory impairment is detected.
Therefore, our results may be explained by taking into 
account the neural correlates of alexithymia and the rela-
tionship between perception and emotion. Alexithymia 
in patients suffering from major depression is associated 
with a decreased anatomical and functional connectivity 
between left and right sensorimotor cortices through the 
corpus callosum, while alexithymia without concurrent 
major depression is associated with altered diffusivity of 
the subcomponent of the right superior longitudinal fas-
cicle that anatomically connects the prefrontal cortex and 
superior occipital lobe (Ho et al. 2016). This points to a 
prominent association of alexithymia with dysfunction in 
the right hemisphere, which is important for emotional 
processing, as well as an impairment in the transfer of 
information between the emotional-dominant and lan-
guage-dominant hemispheres (Ho et al. 2016; Donges and 
Suslow 2017). The relationship between difficulty in iden-
tifying feelings and VDT is in keeping with the involve-
ment of emotions in touch perception (Gazzola et al. 2012; 
Ravaja et al. 2017). Primary somatosensory cortex activa-
tion during interpersonal touch is modulated by the facial 
expression and gender of the touching person, as shown 
by fMRI (Gazzola et al. 2012) and somatosensory-evoked 
potential results data (Ravaja et al. 2017). Recently, TAS-
20 overall, TAS-20 F1 and TAS-20 F2 scores have been 
related to warm perception thresholds in the left upper 
limb of healthy subjects (Borhani et  al. 2017). These 
authors did not log-transform the QST results or evalu-
ate z-scores, in contrast to the suggestions of the German 
Neuropathic Pain Research Network (DFNS) (Geber et al. 
2011; Rolke et al. 2006). Furthermore, warmth detection 
thresholds were evaluated using a reaction-time-dependent 
method of limits. In our study, we did not evaluate warmth 
detection thresholds, and VDT was evaluated using a reac-
tion-time-independent method of levels. Despite these dis-
crepancies, both our study and that of Borhani et al (2017) 
suggest that alexithymia may be associated with process-
ing of sensory inputs from the left of upper limbs, even 
though differently in patients and controls.
Besides alexithymia, in our study, different sensory 
modalities evaluated by QST were also correlated with pain 
intensity ratings (CDT), as well as both state and trait anxi-
ety (HPT), further supporting the association between emo-
tional processing and perception.
Taken together, these observations suggest that psycho-
logical features, including emotional processing, could be 
interpreted also taking into account QST results and NCS. 
QST has been evaluated as a potential biomarker for neuro-
pathic and non-neuropathic pain, and may help to identify a 
possible pathophysiological mechanism underlying pain in 
a patient, thus guiding treatment (Smith et al. 2017; Treede 
2019). Both a subject’s sensory phenotype (Treede 2019) 
and alexithymia (Valdespino et al. 2017) are considered 
trans-diagnostic features (i.e. occurring in patients affected 
by different diseases, but probably stemming from a com-
mon pathophysiology). In our study, alexithymia did not 
differ among patients with CTS, ONP and PBHS, but did 
correlate with a subject’s vibration threshold as a measure 
of loss of mechanoceptor function.
In our study, we did not find any relationship between 
alexithymia and pain intensity: NRS was correlated with 
CDT, in keeping with previous reports suggesting the criti-
cal role of small fibers in the pathophysiology of neuro-
pathic pain (Truini et al. 2009). The association of dorsum 
of hands HPT with state anxiety may be related to the higher 
thermo-sensitivity of hairy proximal skin in the hands (Fil-
ingeri et al., 2018) and the known role of hairy skin ther-
mal receptors in body thermo-regulation. Anxiety and 
thermoregulation are linked (Adriaan Bouwknecht et al., 
2007). Heat stimuli are conveyed to the lateral parabrachial 
nucleus which in turn influence the preoptic hypothalamus 
for thermoregulation (Tansey and Johnson 2015) and the 
central nucleus of the amygdale (Cai et al. 2018). Optogenic 
activation of the latter projection induces acute anxiety-like 
behavior in mice (Cai et al. 2018).
In contrast, alexithymia was correlated with VDT and 
ulnar and median SAP amplitude, thus supporting a distinct 
mechanism. The association between the difficulty identify-
ing feelings and measure of psychological distress, which is 
not the case for pain intensity, is interesting and may war-
rants further investigation.
Taken together, our results suggest a relationship between 
sensory impairment expressed by QST and NCS results and 
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alexithymia and perceived social support, and that alexithy-
mia is related to health quality in patients with neuropathic 
pain, independently of the intensity of pain itself.
Limitations
This study has some limitations that should be considered. 
First, we used self-reported instruments for the assessment 
of psychological, health quality, and social support vari-
ables. With regard to alexithymia, this may have led to an 
underestimation of the presence of participants with alex-
ithymia, in particular of individuals who scored close to the 
cut-off scores. Structured interviews, less dependent on the 
individuals’ awareness levels, should be used, in addition to 
the traditional TAS-20 questionnaire. Second, we adopted 
a cross-sectional design, which does not allow us to draw 
firm conclusions with regard to the causality of the emergent 
relationships. Third, even though we enrolled an adequate 
number of participants, our study is limited by a relatively 
small number of participants, and future studies should 
recruit a larger number of participants. Fourth, we found an 
association between alexithymia and both VDT and sensory 
phenotype with prominent loss of mechanoceptor function, 
but further studies are needed to evaluate a possible causal 
relationship.
Conclusion
Despite the limitations described, the current study sheds 
new light on the correlation between sensory phenotype and 
alexithymia in patients with neuropathic pain in the upper 
limbs. Based on these results, we suggest the importance of 
delivering to these patients personalized care that takes into 
account, from a biopsychosocial perspective, not only the 
neurophysiological aspects but also aspects of their mental 
functioning, especially with regard to their capacity to iden-
tify and describe feelings.
Acknowledgments We thanks Marco Seminario, MD, for his help in 
the study planning.
Funding Open access funding provided by Università degli Studi di 
Torino within the CRUI-CARE Agreement. This study was supported 
by Ministero dell’Istruzione, dell’Università e della Ricerca – MIUR 
project “Dipartimenti di Eccellenza 2018–2022” to Department of 
Neuroscience “Rita Levi Montalcini”. Mauro Adenzato and Rita B. 
Ardito were supported by University of Turin grants (“Ricerca scien-
tifica finanziata dall’Università”).
Compliance with ethical standards 
Conflict of interest All authors have no conflicts of interest and no 
competing interests.
Ethics approval The study was approved by the ethic committee of the 
Hospital “Citta’ della Salute e della Scienza di Torino”, Turin, Italy, 
and participants gave their written informed consent to participate the 
study.
Consent to participate All authors consented to participate.
Consent for publication All authors consented for publication.
Availability of data and material The datasets generated during the 
current study are available from the first author on reasonable request.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
Adriaan Bouwknecht J, Olivier B, Paylor RE (2007) The stress-induced 
hyperthermia paradigm as physiological animal model for anxi-
ety: a review of pharmacological anxiety model in the mouse. 
Neurosci Biobehav Rev 31(1):41–59
American Academy of Neurology (1993) Practice parameters for carpal 
tunnel syndrome. Neurology 43:2406–2409
Backonja MM, Attal N, Baron R, Bouhassira D, Drangholt M, Dyck 
PJ, Edwards RR, Freeman R, Gracely R, Haanpaa MH, Hansson 
P, Hatem SM, Krumova EK, Jensen TS, Maier C, Mick G, Rice 
AS, Rolke R, Treede RD, Serra J, Toelle T, Tugnoli V, Walk D, 
Walalce MS, Ware M, Yarnitsky D, Ziegler D (2013) Value of 
quantitative sensory testing in neurological and pain disorders: 
NeuPSIG consensus. Pain 154:1807–1819
Bagby RM, Parker JDA, Taylor GJ (1994a) The 20-item Toronto Alex-
ithymia Scale, I: Item selection and cross-validation of the factor 
structure. J Psychosom Res 38:23–32
Bagby RM, Parker JDA, Taylor GJ (1994b) The 20-item Toronto Alex-
ithymia Scale, II: Convergent, discriminant, and concurrent valid-
ity. J Psychosom Res 38:33–40
Baliki MN, Apkarian AV (2015) Nociception, pain, negative moods, 
and behavior selection. Neuron 87:474–491
Baron R, Maier C, Attal N, Binder A, Bouhassira D, Cruccu G, 
Finnerup NB, Haanpää M, Hansson P, Hüllemann P, Jensen TS, 
Freynhagen R, Kennedy JD, Magerl W, Mainka T, Reimer M, 
Rice AS, Segerdahl M, Serra J, Sindrup S, Sommer C, Tölle 
T, Vollert J, Treede RD (2017) Peripheral neuropathic pain: a 
mechanism-related organizing principle based on sensory profiles. 
Pain 158:261–272
Beck AT, Steer RA, Brown GK (1996) Beck depression inventory, 2nd 
edn. The Psychological Corporation, San Antonio, TX
70 G. Isoardo et al.
1 3
Borhani K, Làdavas E, Fotopoulou A, Haggard P (2017) “Lacking 
warmth”: Alexithymia trait is related to warm-specific thermal 
somatosensory processing. Biol Psychol 128:132–140
Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle 
J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-
Schluep H, Lantéri-Minet M, Laurent B, Mick G, Serrie A, Valade 
D, Vicaut E (2005) Comparison of pain syndromes associated 
with nervous or somatic lesions and development of a new neu-
ropathic pain diagnostic questionnaire (DN4). Pain 114:29–36
Cai YQ, Wang W, Paulucci-Holthauzen A, Pan ZZ (2018) Brain cir-
cuits mediating opposing effects on emotion and pain. J Neurosci 
38(28):6340–6634
Di Tella M, Adenzato M, Catmur C, Miti F, Castelli L, Ardito RB 
(2020) The role of alexithymia in social cognition: Evidence from 
a non-clinical population. J Affect Disord 273:482–492
Di Tella M, Castelli L (2016) Alexithymia in chronic pain disorders. 
Curr Rheumatol Rep 18:41
Di Tella M, Enrici I, Castelli L, Colonna F, Fusaro E, Ghiggia A, 
Romeo A, Tesio V, Adenzato M (2018) Alexithymia, not fibro-
myalgia, predicts the attribution of pain to anger-related facial 
expressions. J Affect Disord 227:272–279
Donges US, Suslow T (2017) Alexithymia and automatic processing of 
emotional stimuli: a systematic review. Rev Neurosci 28:247–264
Ferrante MA (2004) Brachial plexopathies: classification, causes and 
consequences. Muscle Nerve 30:547–568
Filingeri D, Zhang H, Arens EA (2018) Thermosensory micromap-
ping or warm and cold sensitivity across glabrous and hairy skin 
of male and female hands and feet. J Appl Physiol 125:723–773
Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DL, 
Bouhassira D, Cruccu G, Freeman R, Hansson P, Nurmikko T, 
Raja SN, Rice AS, Serra J, Smith BH, Treede RD, Jensen TS 
(2016) Neuropathic pain: an updated grading system for research 
and clinical practice. Pain 157:1599–1606
Gazzola V, Spezio ML, Etzel JA, Castelli F, Adolphs R, Keysers 
C (2012) Primary somatosensory cortex discriminates affec-
tive significance in social touch. Proc Natl Acad Sci USA 
109:E1657–E1666
Geber C, Klein T, Azad S, Birklein F, Gierthmühlen J, Huge V, 
Lauchart M, Nitzsche D, Stengel M, Valet M, Baron R, Maier 
C, Tölle T, Treede RD (2011) Test-retest and interobserver reli-
ability of quantitative sensory testing according to the protocol of 
the German Research Network on Neuropathic Pain (DFNS): a 
multi-centre study. Pain 152:548–556
Goldberg D, Williams P (1988) A user’s guide to the General Health 
Questionnaire. NFER-Nelson, Windsor, UK
Goslin KL, Krivikas LS (1999) Proximal neuropathies of the upper 
extremity. In: Logigian EL (ed) Neurologic clinics. Entrapment 
and other focal neuropathies. WB Saunders, Philadelphia, pp 
525–548
Ho NS, Wong MM, Lee TM (2016) Neural connectivity of alexithy-
mia: Specific association with major depressive disorder. J Affect 
Disord 193:362–372
Hosoi M, Molton IR, Jensen MP, Ehde DM, Amtmann S, O’Brien S, 
Arimura T, Kubo C (2010) Relationships among alexithymia and 
pain intensity, pain interference, and vitality in persons with neu-
romuscular disease: Considering the effect of negative affectivity. 
Pain 149:273–277
International Association for the study of Pain, terminology [electronic 
source] www.iasp-pain.org. Accessed 9 Mar 2020.
Isoardo G, Stella M, Cocito D, Risso D, Migliaretti G, Cauda F, Pal-
mitessa A, Faccani G, Ciaramitaro P (2012) Neuropathic pain in 
post-burn hypertrophic scars: a psychophysical and neurophysi-
ological study. Muscle Nerve 45:883–890
Jablecki CK, Andary MT, Floeter MK, Miller RG, Quartly CA, Vennix 
MJ, Wilson JR (2002) Practice parameter: electrodiagnostic stud-
ies in carpal tunnel syndrome: report of the American Academy 
of Electrodiagnostic Medicine, American Academy of Neurology 
and the American Academy of Physical Medicine and Rehabilita-
tion. Neurology 58:1593–1598
Jensen MP, McFarland CA (1993) Increasing the Reliability and valid-
ity of pain intensity measurement in chronic pain patients. Pain 
55:195–203
Keefer KV, Taylor GJ, Parker JD, Bagby RM (2019) Taxometric analy-
sis of the Toronto Structured Interview for Alexithymia. Assess-
ment 26:364–374
Kendall FP, Kendall McCreary E, Geise Provance P, Rodgers MM, 
Romani WA (2005) Muscles, testing and function, with posture 
and pain, 5th edn. Lippincott, Baltimore
Lane RD, Weihs KL, Herring A, Hishaw A, Smith R (2015) Affective 
agnosia: expansion of the alexithymia construct and a new oppor-
tunity to integrate and extend Freud’s legacy. Neurosci Biobehav 
Rev 55:594–611
Lumley MA, Neely LC, Burger AJ (2007) The assessment of alex-
ithymia in medical settings: implications for understanding and 
treating health problems. J Pers Assess 89:230–246
Maier C, Baron R, Tölle TR, Binder A, Birbaumer N, Birklein 
F, Gierthmühlen J, Flor H, Geber C, Huge V, Krumova EK, 
Landwehrmeyer GB, Magerl W, Maihöfner C, Richter H, Rolke R, 
Scherens A, Schwarz A, Sommer C, Tronnier V, Uçeyler N, Valet 
M, Wasner G, Treede RD (2010) Quantitative sensory testing in 
the German Research Network on Neuropathic Pain (DFNS): 
somatosensory abnormalities in 1236 patients with different neu-
ropathic pain syndromes. Pain 150:439–450
Margalit D, Ben Har L, Brill S, Vatine JJ (2014) Complex regional pain 
syndrome, alexithymia, and psychological distress. J Psychosom 
Res 77:273–277
Makino S, Jensen MP, Arimura T, Obata T, Anno K, Iwaki R, Kubo C, 
Sudo N, Hosoi M (2013) Alexithymia and chronic pain: the role 
of negative affectivity. Clin J Pain 29:354–361
Meints SM, Edwards RR (2018) Evaluating psychosocial contribu-
tions to chronic pain outcomes. Prog Neuropsychopharmacol Biol 
Psychiatry 87:168–182
Mondelli M, Giannini F, Ballerini M, Ginanneschi F, Martorelli E 
(2005) Incidence of ulnar neuropathy at the elbow in the province 
of Siena (Italy). J Neurol Sci 234:5–10
Nicholas M, Vlaeyen JWS, Rief W, Barke A, Aziz Q, Benoliel R, 
Cohen M, Evers S, Giamberardino MA, Goebel A, Korwisi B, 
Perrot S, Svensson P, Wang SJ, Treede RD (2019) The IASP clas-
sification of chronic pain for ICD-11: chronic primary pain. Pain 
160:28–37
Padua L, Pasqualetti P, Rosenbaum R (2005) One patient, two carpal 
tunnels: statistical and clinical analysis- by hand or by patient? 
Clin Neurophysiol 16:241–243
Perrot S, Cohen M, Barke A, Korwisi B, Rief W, Treede RD (2019) 
The IASP classification of chronic pain for ICD-11: Chronic sec-
ondary musculoskeletal pain. Pain 160:77–82
Preston DC (1999) Distal median neuropathies. In: Logigian EL (ed) 
Neurologic clinics. Entrapment and other focal neuropathies. WB 
Saunders, Philadelphia, pp 407–424
Ravaja N, Harjunen V, Ahmed I, Jacucci G, Spapé MM (2017) Feeling 
touched: emotional modulation of somatosensory potentials to 
interpersonal touch. Sci Rep 7:40504
Rolke R, Baron R, Maier C, Tölle TR, Treede RD, Beyer A, Binder A, 
Birbaumer N, Birklein F, Bötefür IC, Braune S, Flor H, Huge V, 
Klug R, Landwehrmeyer GB, Magerl W, Maihöfner C, Rolko C, 
Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B (2006) 
Quantitative sensory testing in the German Research Network on 
Neuropathic Pain (DFNS): Standardised protocol and reference 
values. Pain 123:231–243
Rosenberger DC, Blechschmidt V, Timmerman H, Wolff A, Treede RD 
(2020) Challenges of neuropathic pain: focus on diabetic neuropa-
thy. J Neural Transm 127:589–624
71The relationship between alexithymia, sensory phenotype and neurophysiological parameters…
1 3
Saariaho AS, Saariaho TH, Mattila AK, Karukivi M, Joukamaa MI 
(2015) Alexithymia and early maladaptive schemas in chronic 
pain patients. Scand J Psychol 56:428–437
Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, 
Benoliel R, Cohen M, Cruccu G, Davis KD, Evers S, First M, 
Giamberardino MA, Hansson P, Kaasa S, Korwisi B, Kosek E, 
Lavandʼhomme P, Nicholas M, Nurmikko T, Perrot S, Raja SN, 
Rice ASC, Rowbotham MC, Schug S, Simpson DM, Smith BH, 
Svensson P, Vlaeyen JWS, Wang SJ, Barke A, Rief W, Treede 
RD (2019) The IASP classification of chronic pain for ICD-11: 
chronic neuropathic pain. Pain 160:53–59
Schug SA, Lavandʼhomme P, Barke A, Korwisi B, Rief W, Treede RD, 
IASP Taskforce for the Classification of Chronic Pain (2019) The 
IASP classification of chronic pain for ICD-11: chronic postsurgi-
cal or posttraumatic pain. Pain 160(1):45–52
Seror P (2002) The medial antebrachial cutaneous nerve: antidromic 
and orthodromic conduction studies. Muscle Nerve 26:421–423
Sifneos PE (1973) The prevalence of “alexithymic” characteristics in 
psychosomatic patients. Psychother Psychosom 22:255–262
Smith SM, Dworkin RH, Turk DC, Baron R, Polydefkis M, Tracey I, 
Borsook D, Edwards RR, Harris RE, Wager TD, Arendt-Nielsen 
L, Burke LB, Carr DB, Chappell A, Farrar JT, Freeman R, Gilron 
I, Goli V, Haeussler J, Jensen T, Katz NP, Kent J, Kopecky EA, 
Lee DA, Maixner W, Markman JD, McArthur JC, McDermott 
MP, Parvathenani L, Raja SN, Rappaport BA, Rice ASC, Row-
botham MC, Tobias JK, Wasan AD, Witter J (2017) The potential 
role of sensory testing, skin biopsy, and functional brain imaging 
as biomarkers in chronic pain clinical trials: IMMPACT Consid-
erations. J Pain 18:757–777
Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA (1983) 
State-trait anxiety inventory (form Y). Mind Garden, Palo Alto
Tansey EA, Johnson CD (2015) Recent advances in thermoregulation. 
Adv Physiol Educ 39(3):139–148
Treede RD (2019) The role of quantitative sensory testing in the predic-
tion of chronic pain. Pain 160:S66–S69
Truini A, Padua L, Biasiotta A, Caliandro P, Pazzaglia C, Galeotti F, 
Inghilleri M, Cruccu G (2009) Differential involvement of A-delta 
and A-beta fibres in neuropathic pain related to carpal tunnel syn-
drome. Pain 145:105–109
Turk DC, Audette J, Levy RM, Mackey SC, Stanos S (2010) Assess-
ment and treatment of psychosocial comorbidities in patients with 
neuropathic pain. Mayo Clin Proc 85:S42–S50
Vachon-Presseau E, Centeno MV, Ren W, Berger SE, Tétreault P, 
Ghantous M, Baria A, Farmer M, Baliki MN, Schnitzer TJ, Apka-
rian AV (2016) The emotional brain as a predictor and amplifier 
of chronic pain. J Dent Res 95:605–612
Valdespino A, Antezana L, Ghane M, Richey JA (2017) Alexithymia 
as a transdiagnostic precursor to empathy abnormalities: the func-
tional role of the insula. Front Psychol 8:2234
Wade RG, Takwoingi Y, Wormald JCR, Ridgway JP, Tanner S, Rank-
ine JJ, Bourke G (2018) Magnetic resonance imaging for detecting 
root avulsions in traumatic adult brachial plexus injuries: protocol 
for a systematic review of diagnostic accuracy. Syst Rev 7:76
Zimet GD, Dahlem N, Zimet SG, Farley GK (1988) The multidimen-
sional scale of perceived social support. J Pers Assess 52:30–41
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
